These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29908763)

  • 1. Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review.
    Behar E; Bagnulo R; Coffin PO
    Prev Med; 2018 Sep; 114():79-87. PubMed ID: 29908763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes Toward Naloxone Prescribing in Clinical Settings: A Qualitative Study of Patients Prescribed High Dose Opioids for Chronic Non-Cancer Pain.
    Mueller SR; Koester S; Glanz JM; Gardner EM; Binswanger IA
    J Gen Intern Med; 2017 Mar; 32(3):277-283. PubMed ID: 27798775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing an overdose education and naloxone distribution program in a health system.
    Devries J; Rafie S; Polston G
    J Am Pharm Assoc (2003); 2017; 57(2S):S154-S160. PubMed ID: 28233681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability of Naloxone Co-Prescription Among Primary Care Providers Treating Patients on Long-Term Opioid Therapy for Pain.
    Behar E; Rowe C; Santos GM; Coffa D; Turner C; Santos NC; Coffin PO
    J Gen Intern Med; 2017 Mar; 32(3):291-295. PubMed ID: 27815762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff.
    Binswanger IA; Koester S; Mueller SR; Gardner EM; Goddard K; Glanz JM
    J Gen Intern Med; 2015 Dec; 30(12):1837-44. PubMed ID: 26055224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical providers' knowledge and concerns about opioid overdose education and take-home naloxone rescue kits within Veterans Affairs health care medical treatment settings.
    Winograd RP; Davis CS; Niculete M; Oliva E; Martielli RP
    Subst Abus; 2017; 38(2):135-140. PubMed ID: 28486076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
    Kohan LR; Elmofty D; Pena I; Liao C
    J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review.
    Moustaqim-Barrette A; Dhillon D; Ng J; Sundvick K; Ali F; Elton-Marshall T; Leece P; Rittenbach K; Ferguson M; Buxton JA
    BMC Public Health; 2021 Mar; 21(1):597. PubMed ID: 33771150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid Overdose and Naloxone Kit Distribution: A Quality Assurance Educational Program in the Primary Care Setting.
    Lockett TL; Hickman KL; Fils-Guerrier BJ; Lomonaco M; Maye JP; Rossiter AG
    J Addict Nurs; 2018; 29(3):157-162. PubMed ID: 30180000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Legal requirements and recommendations to prescribe naloxone.
    Haffajee RL; Cherney S; Smart R
    Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program.
    Oliva EM; Christopher MLD; Wells D; Bounthavong M; Harvey M; Himstreet J; Emmendorfer T; Valentino M; Franchi M; Goodman F; Trafton JA;
    J Am Pharm Assoc (2003); 2017; 57(2S):S168-S179.e4. PubMed ID: 28292502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.
    Mueller SR; Walley AY; Calcaterra SL; Glanz JM; Binswanger IA
    Subst Abus; 2015; 36(2):240-53. PubMed ID: 25774771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Take-Home Naloxone and Opioid Overdose Reversals Performed by Patients in an Opioid Treatment Program.
    Katzman JG; Takeda MY; Greenberg N; Moya Balasch M; Alchbli A; Katzman WG; Salvador JG; Bhatt SR
    JAMA Netw Open; 2020 Feb; 3(2):e200117. PubMed ID: 32101312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone for Opioid Overdose and the Role of the Pharmacist.
    Toderika Y; Williams S
    Consult Pharm; 2018 Feb; 33(2):98-104. PubMed ID: 29409576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessment.
    Bounthavong M; Suh K; Christopher MLD; Veenstra DL; Basu A; Devine EB
    Res Social Adm Pharm; 2020 Aug; 16(8):1033-1040. PubMed ID: 31706950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The feasibility of employing a home healthcare model for education and treatment of opioid overdose using a naloxone auto-injector in a private practice pain medicine clinic.
    Dragovich A; Brason F; Beltran T; McCoart A; Plunkett AR
    Curr Med Res Opin; 2018 Dec; 34(12):2137-2141. PubMed ID: 29667452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone Counseling for Harm Reduction and Patient Engagement.
    Han JK; Hill LG; Koenig ME; Das N
    Fam Med; 2017 Oct; 49(9):730-733. PubMed ID: 29045991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonrandomized Intervention Study of Naloxone Coprescription for Primary Care Patients Receiving Long-Term Opioid Therapy for Pain.
    Coffin PO; Behar E; Rowe C; Santos GM; Coffa D; Bald M; Vittinghoff E
    Ann Intern Med; 2016 Aug; 165(4):245-52. PubMed ID: 27366987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring Providers' Perception to Naloxone Education for Opioid Overdose After Receiving Academic Detailing at the U.S. Department of Veterans Affairs.
    Bounthavong M; Christopher MLD; Veenstra DL; Basu A; Devine EB
    J Pharm Pract; 2023 Jun; 36(3):514-522. PubMed ID: 34766510
    [No Abstract]   [Full Text] [Related]  

  • 20. Establishment of a pharmacist-led service for patients at high risk for opioid overdose.
    Tewell R; Edgerton L; Kyle E
    Am J Health Syst Pharm; 2018 Mar; 75(6):376-383. PubMed ID: 29523534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.